Insider Selling: Astera Labs (NASDAQ:ALAB) COO Sells 95,444 Shares of Stock

Astera Labs, Inc. (NASDAQ:ALABGet Free Report) COO Sanjay Gajendra sold 95,444 shares of the stock in a transaction dated Monday, May 18th. The shares were sold at an average price of $225.02, for a total value of $21,476,808.88. Following the completion of the transaction, the chief operating officer owned 1,435,857 shares in the company, valued at approximately $323,096,542.14. The trade was a 6.23% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Sanjay Gajendra also recently made the following trade(s):

  • On Thursday, May 7th, Sanjay Gajendra sold 49,361 shares of Astera Labs stock. The shares were sold at an average price of $199.21, for a total value of $9,833,204.81.
  • On Thursday, May 7th, Sanjay Gajendra sold 230,639 shares of Astera Labs stock. The shares were sold at an average price of $198.22, for a total value of $45,717,262.58.

Astera Labs Price Performance

Shares of ALAB traded up $43.22 during mid-day trading on Wednesday, reaching $287.48. The company’s stock had a trading volume of 10,253,769 shares, compared to its average volume of 5,914,570. Astera Labs, Inc. has a 12-month low of $84.78 and a 12-month high of $287.70. The stock has a market cap of $49.28 billion, a PE ratio of 194.24, a price-to-earnings-growth ratio of 3.23 and a beta of 3.35. The company’s 50 day moving average is $163.12 and its 200 day moving average is $157.97.

Astera Labs (NASDAQ:ALABGet Free Report) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. During the same quarter in the prior year, the business posted $0.33 EPS. The business’s revenue for the quarter was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, sell-side analysts anticipate that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Institutional Trading of Astera Labs

A number of hedge funds have recently added to or reduced their stakes in the stock. Liontrust Investment Partners LLP lifted its position in Astera Labs by 98.7% during the 1st quarter. Liontrust Investment Partners LLP now owns 105,270 shares of the company’s stock worth $11,538,000 after acquiring an additional 52,284 shares during the period. SOA Wealth Advisors LLC. acquired a new stake in Astera Labs during the 1st quarter worth approximately $49,000. E20 Capital Ltd acquired a new stake in Astera Labs during the 1st quarter worth approximately $33,310,000. Silicon Valley Capital Partners lifted its position in Astera Labs by 233.3% during the 1st quarter. Silicon Valley Capital Partners now owns 1,000 shares of the company’s stock worth $110,000 after acquiring an additional 700 shares during the period. Finally, Bank of America Corp DE lifted its position in Astera Labs by 20.1% during the 1st quarter. Bank of America Corp DE now owns 1,788,232 shares of the company’s stock worth $195,990,000 after acquiring an additional 299,415 shares during the period. 60.47% of the stock is owned by institutional investors and hedge funds.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on ALAB shares. Citigroup raised their price target on Astera Labs from $200.00 to $245.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th. Loop Capital started coverage on Astera Labs in a research note on Thursday, March 5th. They set a “buy” rating and a $250.00 price target on the stock. Royal Bank Of Canada raised their price target on Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 6th. Jefferies Financial Group restated a “buy” rating and set a $270.00 price target on shares of Astera Labs in a research note on Wednesday, May 6th. Finally, UBS Group started coverage on Astera Labs in a research note on Tuesday, April 21st. They set a “neutral” rating and a $180.00 price target on the stock. Fifteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $233.75.

Read Our Latest Stock Analysis on Astera Labs

Astera Labs Company Profile

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Read More

Insider Buying and Selling by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.